The upsurge in circulating IL-18 levels may signify a state of chronic inflammation within the brain, and its overexpression could potentially trigger tau protein phosphorylation, consequently contributing to neurodegeneration in Alzheimer's Disease (AD) patients (18). Here, IL18 is linked to early-onset autosomal dominant Alzheimer disease.